Physio AI already scales past 650 clinics. Site differences are not the barrier they sound like.

"Our downtown clinic runs nothing like our suburban one. Different caseload, different staff, different rhythm. AI will just be one more system that works at one site and not the other." That is the shape the objection takes when a physio practice manager brings AI scheduling or documentation tools to an owner weighing a second or third location. It is a fair instinct from someone who has watched a platform demo well in a boardroom and then collapse the moment real clinics with real quirks touch it. It is also an assumption worth testing against what is actually happening in the market, because multi-site physical therapy groups are not a hypothetical case study. They are increasingly the default.

The "too different" premise does not match the physio market

Outpatient physical therapy in the US remains a fragmented market, an estimated 37,000 to 38,000 clinics nationwide with no single operator holding more than a small share (Harris Williams physical therapy market overview, 2022, cited via WebPT's State of Rehab Therapy analysis). But fragmented does not mean single-site. Multi-clinic platforms have been consolidating that fragmentation for years: Ivy Rehab operates more than 650 clinics as of 2025 (company disclosure via PitchBook), Athletico Physical Therapy runs more than 550 clinics under Golden Gate Capital and BDT Capital Partners ownership, and FYZICAL Therapy and Balance Centers, a franchise model, disclosed more than 500 locations across 45-plus states in 2025 (CT Acquisitions, Physical Therapy Practice M&A Multiples Report 2026, July 1, 2026, citing Modern Healthcare, Wall Street Journal, and company disclosures). Private equity has deployed more than $1 trillion into healthcare over the last decade, and deal volume in outpatient rehab specifically grew more than 10% year over year into 2026.

None of those platforms got to 500-plus locations by declaring every clinic too unique to run on shared systems. They got there by coordinating scheduling, documentation, and patient communication across sites that are, by definition, staffed and run differently from one another. If genuine site-to-site difference made shared software unworkable, that scale of consolidation would already be failing.

So what this means for your practice: the assumption that your two clinics are unusually inconsistent, and therefore a special case AI cannot handle, is worth checking against the data before it becomes the reason you rule standardization out. The largest operators in your market are already managing exactly this problem.

What the software actually does with real differences

The objection carries a real point inside it. A platform that forces identical settings on every clinic regardless of staffing, hours, or caseload would create precisely the mess the myth predicts. That is not how enterprise rehab therapy software is built. Vendors selling to multi-location practice groups describe centralized management sitting above local variation, cross-location scheduling visibility and consolidated analytics at the network level, with scheduling rules, staffing, and service mix configured per clinic underneath it (composite of 2026 multi-location PT software vendor materials, treat as vendor-sourced description of product architecture). The model is a shared baseline plus local configuration, not one-size-fits-all.

That structure inverts what the myth assumes. The software is not asking your downtown and suburban clinics to become identical. It is asking you to decide, deliberately, which parts of the patient experience should be consistent everywhere, how fast a call gets returned, what a recall message says, how documentation gets structured, and which parts should stay local, staffing patterns, hours, caseload mix. Those are two different decisions, and most of the "too different" objection comes from treating them as one.

So what this means for your practice: before ruling AI out because your clinics differ, split your actual differences into two lists, the ones that should stay different and the ones that are only different because nobody has standardized them yet. The second list is where the business case lives.

What inconsistency actually costs, with numbers attached

Physical therapy has a well-documented no-show problem, and it is worse than most owners assume. A peer-reviewed study of musculoskeletal outpatient physical therapy found 73% of patients missed at least one scheduled appointment during their episode of care (PLOS ONE, "Prevalence and predictors of no-shows to physical therapy for musculoskeletal conditions"). Separately, industry benchmark research across multiple healthcare settings shows that 60% to 70% of no-shows are generated by 15% to 20% of the patient base, the same pattern already documented for dental practices. At a single clinic, front-desk staff often carry that knowledge informally, they know which patients need a phone call instead of a text reminder. That knowledge does not travel between clinics. A patient who reliably no-shows at your downtown location is a first-time unknown to the front desk at your suburban one, and the practice pays for that gap twice, once in lost treatment slots and again in staff time spent re-learning a pattern that already existed somewhere in the business.

This is exactly the coordination problem AI scheduling and recall tools exist to close: replacing informal, site-specific staff memory with a shared record that behaves the same way no matter which clinic a patient calls. A practice that avoids standardizing because "each clinic is different" is choosing to keep paying for that gap rather than closing it.

So what this means for your practice: run the numbers on your own two sites. If a patient who reliably misses appointments at one clinic is treated as a fresh no-show risk at the other, that is not proof AI cannot standardize your practice. It is proof you are currently unstandardized in a way that is already costing you treatment capacity.

Proof this works past two or three clinics

Ivy Rehab, founded in 2003 and now one of the fastest-growing outpatient physical, occupational, speech therapy, and ABA networks in the country, announced on February 4, 2026 that it had selected Raintree as its enterprise EMR partner and had already rolled out Raintree's ambient scribe tool, ScribeIQ, across its entire adult clinician portfolio, every clinician, every adult patient visit (Raintree Systems, press release, February 4, 2026). Ivy Rehab is now extending that same platform's NoteIQ and SchedulerIQ tools, covering documentation and scheduling specifically, across the network through the rest of 2026. Raintree itself states it processes more than 50 million patient visits a year across more than 8,500 clinics nationwide (Raintree Systems, company materials, 2026, vendor-published, treat as a vendor claim about its own reach).

That is not a single flip-the-switch deployment. It is a staged rollout across a network built from years of growth, meaning it inherited exactly the kind of site-by-site variation in staffing, hours, and caseload a two-clinic group worries about, at a scale many multiples larger. Industry deployment guidance for multi-location healthcare AI rollouts generally recommends the sequence Ivy Rehab's own scale effectively required: a single-clinic pilot of 60 to 90 days with defined success metrics, a written playbook built from what that pilot shows, and rollout in cohorts rather than everywhere at once (2026 vendor and consultant guidance, not independently verified, treat as informed industry practice rather than a controlled study). Rollouts that skip that sequence, deploying to every clinic simultaneously with no pilot and no playbook, are the ones that end up configured inconsistently by whoever happened to set each site up.

So what this means for your practice: a two- or three-site independent group has an advantage a 650-clinic network does not, far fewer sites to stage. Pilot the tool at your busiest or most data-friendly clinic for 60 to 90 days, write down exactly what worked, then apply that playbook to the second site before a third one is even on the table. The sequencing that takes an enterprise platform a year takes an independent group a single quarter.

The call

The evidence does not support the idea that your clinics are too different for AI to work across them. It supports a narrower, more useful claim: standardization fails when it is deployed without a sequence, not when it is deployed across more than one site. Before you write off AI as something only enterprise-scale rehab networks can pull off, or add a third location without a plan for consistency, separate what should genuinely stay local at each of your clinics from what is only inconsistent because nobody has standardized it yet, then pilot the fix at one site before rolling it to the rest.

For a scored, independent read on where scheduling, recall, and documentation consistency actually stand across your existing clinics before you build the business case for a third, the AI Opportunity and Growth Assessment covers exactly that comparison. Start with a free 20-minute discovery call.

See also: the same objection, tested against dental's multi-site data, how Cliniko, Jane, and WriteUpp compare for a growing physio practice, and the bundled-versus-standalone AI scribe decision.

Related: Dental AI already standardizes across 1,900 locations · Cliniko vs Jane vs WriteUpp: the physio PMS verdict · $15 vs $150: the physio AI scribe decision